{"pmid":32355116,"title":"Unknown Unknowns: Surgical Consent during the COVID-19 Pandemic.","text":["Unknown Unknowns: Surgical Consent during the COVID-19 Pandemic.","Ann Surg","Bryan, Ava Ferguson","Milner, Ross","Roggin, Kevin K","Angelos, Peter","Matthews, Jeffrey B","32355116"],"journal":"Ann Surg","authors":["Bryan, Ava Ferguson","Milner, Ross","Roggin, Kevin K","Angelos, Peter","Matthews, Jeffrey B"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32355116","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1097/SLA.0000000000003995","topics":["Prevention"],"weight":1,"_version_":1666138495192662018,"score":9.490897,"similar":[{"pmid":32247898,"title":"Unknown unknowns - COVID-19 and potential global mortality.","text":["Unknown unknowns - COVID-19 and potential global mortality.","COVID-19 (SARS-CoV-2) is currently a global pandemic. This paper will attempt to estimate global infection rates and potential resultant mortality in the absence of effective treatment and/or vaccination. Calculations are based on World Health Organisation data from Wuhan in China: 14% of infected cases are severe, 5% require intensive care and 4% die. Estimated infection rates and mortality rates at the level of continents and some individual countries (when these are of sufficient size) are tabulated. This pandemic may cause close to half a billion deaths, i.e. 6% of the global population - and potentially more. At the risk of sounding sensational, but with a sober sense of realism, healthcare risks being plunged into the Middle-Ages if the public do not do their part. Infection cannot occur in the absence of contact. The only way to mitigate these numbers is to apply social distancing and take the standard precautions so frequently reiterated by Public Health: hand washing, avoid touching the face and so on. These measures are crucial as the human cost is going to be unthinkable even in the best-case scenarios that epidemiologists are modelling.","Early Hum Dev","Grech, Victor","32247898"],"abstract":["COVID-19 (SARS-CoV-2) is currently a global pandemic. This paper will attempt to estimate global infection rates and potential resultant mortality in the absence of effective treatment and/or vaccination. Calculations are based on World Health Organisation data from Wuhan in China: 14% of infected cases are severe, 5% require intensive care and 4% die. Estimated infection rates and mortality rates at the level of continents and some individual countries (when these are of sufficient size) are tabulated. This pandemic may cause close to half a billion deaths, i.e. 6% of the global population - and potentially more. At the risk of sounding sensational, but with a sober sense of realism, healthcare risks being plunged into the Middle-Ages if the public do not do their part. Infection cannot occur in the absence of contact. The only way to mitigate these numbers is to apply social distancing and take the standard precautions so frequently reiterated by Public Health: hand washing, avoid touching the face and so on. These measures are crucial as the human cost is going to be unthinkable even in the best-case scenarios that epidemiologists are modelling."],"journal":"Early Hum Dev","authors":["Grech, Victor"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32247898","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.earlhumdev.2020.105026","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138492008136704,"score":92.25511},{"pmid":32287787,"pmcid":"PMC7131653","title":"Deadly unknowns.","text":["Deadly unknowns.","We are still scrambling to understand how dangerous the Wuhan coronavirus is.","New Sci","32287787"],"abstract":["We are still scrambling to understand how dangerous the Wuhan coronavirus is."],"journal":"New Sci","date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287787","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S0262-4079(20)30233-5","locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1666138491370602496,"score":86.65553},{"pmid":32188753,"pmcid":"PMC7082143","title":"COVID-19: Knowns, Unknowns, and Questions.","text":["COVID-19: Knowns, Unknowns, and Questions.","The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Hubei province in China in late 2019 demonstrates the epidemic potential of coronaviruses. The rapid spread of this virus across the world in only 2 months highlights the transmissibility of this family of viruses and the significant morbidity and mortality that they can cause. We highlight the current state of knowledge of coronavirus biology while answering questions concerning the current outbreak of SARS-CoV-2.","mSphere","Weston, Stuart","Frieman, Matthew B","32188753"],"abstract":["The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Hubei province in China in late 2019 demonstrates the epidemic potential of coronaviruses. The rapid spread of this virus across the world in only 2 months highlights the transmissibility of this family of viruses and the significant morbidity and mortality that they can cause. We highlight the current state of knowledge of coronavirus biology while answering questions concerning the current outbreak of SARS-CoV-2."],"journal":"mSphere","authors":["Weston, Stuart","Frieman, Matthew B"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32188753","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.1128/mSphere.00203-20","keywords":["covid-19","sars","sars-cov-2","coronavirus"],"locations":["Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Transmission"],"weight":1,"_version_":1666138490571587584,"score":76.097755},{"pmid":32437587,"title":"COVID-19 vaccines: knowing the unknown.","text":["COVID-19 vaccines: knowing the unknown.","Vaccine development against SARS-CoV-2 has drawn attention around the globe due to the exploding pandemic. Although COVID-19 is caused by a new coronavirus, SARS-CoV-2, previous research on other coronavirus vaccines, such as FIPV, SARS and MERS, has provided valuable information for the rapid development of COVID-19 vaccine. However, important knowledge gaps remain - some are specific to SARS-CoV-2, others are fundamental to immunology and vaccinology. Here we discuss areas that need to be addressed for COVID-19 vaccine development, and what can be learned from examples of vaccine development in the past. Since the beginning of the outbreak, the research progress on COVID-19 has been remarkable. We are therefore optimistic about the rapid development of COVID-19 vaccine. This article is protected by copyright. All rights reserved.","Eur J Immunol","Lv, Huibin","Wu, Nicholas C","Mok, Chris K P","32437587"],"abstract":["Vaccine development against SARS-CoV-2 has drawn attention around the globe due to the exploding pandemic. Although COVID-19 is caused by a new coronavirus, SARS-CoV-2, previous research on other coronavirus vaccines, such as FIPV, SARS and MERS, has provided valuable information for the rapid development of COVID-19 vaccine. However, important knowledge gaps remain - some are specific to SARS-CoV-2, others are fundamental to immunology and vaccinology. Here we discuss areas that need to be addressed for COVID-19 vaccine development, and what can be learned from examples of vaccine development in the past. Since the beginning of the outbreak, the research progress on COVID-19 has been remarkable. We are therefore optimistic about the rapid development of COVID-19 vaccine. This article is protected by copyright. All rights reserved."],"journal":"Eur J Immunol","authors":["Lv, Huibin","Wu, Nicholas C","Mok, Chris K P"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437587","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/eji.202048663","keywords":["covid-19","sars-cov-2","vaccine"],"topics":["Treatment"],"weight":1,"_version_":1667521393510580224,"score":76.097755},{"pmid":32310242,"pmcid":"PMC7162640","title":"The Known into the Unknown: Brugada syndrome and COVID-19.","text":["The Known into the Unknown: Brugada syndrome and COVID-19.","JACC Case Rep","Sorgente, Antonio","Capulzini, Lucio","Brugada, Pedro","32310242"],"journal":"JACC Case Rep","authors":["Sorgente, Antonio","Capulzini, Lucio","Brugada, Pedro"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310242","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaccas.2020.04.006","keywords":["brugada syndrome","covid-19","sudden cardiac death"],"locations":["Brugada"],"topics":["Treatment"],"weight":1,"_version_":1666138491180810240,"score":71.72821}]}